The SwissPrEPared Study
NCT03893188 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2023-04-06
Summary
Nested within the SwissPrEPared Program, the "SwissPrEPared Study" - a large, multicentric, nation-wide cohort study - aims to longitudinally follow individuals asking for PrEP prescription over a period of 3 years.
Conditions
- HIV Preexposure Prophylaxis
Sponsors & Collaborators
-
Swiss HIV Cohort Study
collaborator NETWORK -
Federal Office of Public Health, Switzerland
collaborator OTHER_GOV -
Positive Council Switzerland
collaborator UNKNOWN -
Cantonal Hospital St. Gallen
collaborator UNKNOWN -
University Hospital, University of Bern
collaborator UNKNOWN -
Cantonal Hosptal, Baselland
collaborator OTHER -
University Hospital, Geneva
collaborator OTHER -
University of Lausanne Hospitals
collaborator OTHER -
University Hospital, Basel, Switzerland
collaborator OTHER -
University of Zurich
lead OTHER
Principal Investigators
-
Benjamin Hampel, MD · University of Zurich
Eligibility
- Min Age
- 16 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-04-10
- Primary Completion
- 2030-03-31
- Completion
- 2030-03-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Evaluation of Patients Who Have Not Had Success With Zidovudine
NCT00001025 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
NCT00002334 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
NCT00000736 ·Status: COMPLETED ·Phase: PHASE3
-
Study Examining PrEP-001 in Subjects With Asthma
NCT03296917 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Disease Progression and Anti-HIV Treatments
NCT00001068 ·Status: COMPLETED ·Phase: PHASE2
-
Depot Disulfiram for AIDS and ARC
NCT00002065 ·Status: COMPLETED ·Phase: NA
-
Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline
NCT06069141 ·Status: RECRUITING ·Phase: NA
-
Triage Survey for Infectious Disease Eligibility
NCT06492187 ·Status: RECRUITING
-
Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)
NCT00002063 ·Status: COMPLETED ·Phase: NA
-
Regional Multicenter Study to Evaluate Tolerability and Efficacy of TAF/FTC/RPV Combination (ODEFSEY ®) in Prevention of Sexual or Blood Exposure to HIV
NCT03451032 ·Status: COMPLETED
-
Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex
NCT00000692 ·Status: COMPLETED ·Phase: PHASE1
-
Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol
NCT03517358 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
NCT00000823 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus
NCT00000993 ·Status: COMPLETED ·Phase: NA
-
Syphilis Self-testing to Expand Test Uptake Among Men Who Have Sex With Men (SST)
NCT04480749 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS
NCT00001024 ·Status: COMPLETED ·Phase: NA
-
A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT
NCT00001032 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients
NCT00002363 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)
NCT00000742 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of 935U83 in HIV-Infected Patients
NCT00002338 ·Status: COMPLETED ·Phase: PHASE1
-
An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan
NCT06156982 ·Status: COMPLETED
-
Efficacy of Doxycycline Prophylaxis to Reduce Syphilis in High-Risk, HIV-Positive MSM
NCT02257658 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine
NCT00000734 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC
NCT00000999 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors
NCT00007449 ·Status: UNKNOWN ·Phase: PHASE2